A comprehensive eight-year study examining audiological outcomes of newborns screened for congenital cytomegalovirus (cCMV) ...

For some truckers in Kansas, the road may end with a language barrier. Six months ago, President Trump issued an executive ...

For some truckers in Kansas, the road may end with a language barrier. Six months ago, President Trump issued an executive ...

The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of ...

English speaking commercial drivers out of service - threatening supply chains for key ingredients and grocery CPGs.

Moderna is halting development of an mRNA vaccine for congenital cytomegalovirus after its candidate failed to protect women from the virus in a large phase 3 trial, the biotech announced in a ...

Our immune response is not fixed. It is a living, adaptive network of cells and signals that evolves over our lifespan, ...

Moderna had hoped its shot would be at least 49% effective at preventing CMV infections, substantially reducing the risk of passing the virus to newborns. But top-line data the company released ...

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...